Skandinaviska Enskilda Banken (SEB)’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,972
| Closed | -$414K | – | 1041 |
|
|
2021
Q4 | $414K | Sell |
1,972
-2,079
| -51% | -$436K | ﹤0.01% | 859 |
|
|
2021
Q3 | $1.09M | Hold |
4,051
| – | – | 0.01% | 771 |
|
|
2021
Q2 | $1.04M | Buy |
+4,051
| New | +$1.04M | 0.01% | 805 |
|
|
2019
Q4 | – | Sell |
-1,150
| Closed | -$314K | – | 950 |
|
|
2019
Q3 | $314K | Sell |
1,150
-973
| -46% | -$266K | ﹤0.01% | 826 |
|
|
2019
Q2 | $1.13M | Buy |
2,123
+237
| +13% | +$127K | 0.01% | 633 |
|
|
2019
Q1 | $952K | Sell |
1,886
-270
| -13% | -$136K | 0.01% | 601 |
|
|
2018
Q4 | $1.06M | Buy |
2,156
+701
| +48% | +$346K | 0.01% | 632 |
|
|
2018
Q3 | $1.33M | Sell |
1,455
-146
| -9% | -$133K | 0.01% | 611 |
|
|
2018
Q2 | $1.17M | Buy |
1,601
+634
| +66% | +$465K | 0.01% | 594 |
|
|
2018
Q1 | $1.54M | Buy |
+967
| New | +$1.54M | 0.01% | 470 |
|